Showing results (1891-1900 of 6,739) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|May 23, 2020
NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal TransitionHui Tong, Xiaohui Liu, Tao Li, et al.Oncotargets and Therapy|May 23, 2020
Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma CellsJingyi Tan, Wenfeng Xu, Lei Lei, et al.Oncotargets and Therapy|September 17, 2021
CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5pZhenYu Shen, ShengHua SunOncotargets and Therapy|September 13, 2021
A Preliminary Study on the Pathogenesis of Colorectal Cancer by Constructing a Hsa-circRNA-0067835-miRNA-mRNA Regulatory NetworkNing Liu, Fan Jiang, Zhiju ChenOncotargets and Therapy|September 13, 2021
Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial ChemoembolizationHao Li, Manzhou Wang, Pengfei Chen, et al.Oncotargets and Therapy|May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibFei-Yu Niu, Yi-Long WuOncotargets and Therapy|May 23, 2015
Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cellsYanling Li, Yuping Li, Qiang Liu, et al.Oncotargets and Therapy|May 23, 2015
A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutationYuguo Liu, Lijuan Luan, Xingli WangOncotargets and Therapy|May 7, 2015
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyondZeyad Kanaan, Goetz H Kloecker, Ajit Paintal, et al.Oncotargets and Therapy|April 22, 2015
A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancerRong Xia, Sunxiao Chen, Yan Chen, et al.Pageof 674